Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research groups


Marta Pereira


Research Assistant


After a BSc in Clinical Psychology (2007) I obtained a MSc in Neuropsychology from the University of Porto (Portugal) in 2009. I then moved to São Paulo (Brazil) where I obtained a PhD degree in Neurosciences at the University of São Paulo in 2019. During this period I had the opportunity to spend some time at the Visual Attention Lab (UMass Boston, USA) as a visiting researcher where I worked with Prof. Marc Pomplun and his team. After obtaining my PhD degree I moved back to Europe and started my current position as a Research Assistant in the Neurometrology lab (University of Oxford).


My research interests lie on cognitive decline and dementia processes in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease (PD) and Progressive Supranuclear Palsy (PSP).

My research and clinical work involves the use of eye tracking systems and other wearable devices to study a wide range of cognitive and motor symptoms that manifest differently in each stage of these diseases.

At the Neurometrology Lab I currently work on finding new ways of measuring symptoms in PD and PSP. My goal is to use wearable technology to distinguish PSP from other Parkinsonian syndromes and to objectively track the progression of cognitive, oculomotor and gait impairments. 

Simultaneously I help to deliver the "Art in Neuroscience" project, a Neurometrology Lab initiative in collaboration with the Ashmolean Museum in Oxford. "Art in Neuroscience" aims to gather researchers, patients and the general public together to talk about Parkinson's disease through the medium of fine arts.